Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Petra Volná"'
Autor:
Raymond J. Monnat, Barry L. Stoddard, Andrew M. Scharenberg, Sarah K. Baxter, Jordan Jarjour, Petra Volná, Steve R. Roffler
Publikováno v:
Nucleic Acids Research
LAGLIDADG homing endonucleases (LHEs) cleave 18–24 bp DNA sequences and are promising enzymes for applications requiring sequence-specific DNA cleavage amongst genome-sized DNA backgrounds. Here, we report a method for cell surface display of LHEs,
Autor:
Pavel Lebduška, Marie Malissen, Petr Dráber, Petr Heneberg, Petra Volná, Lubica Dráberová, Viktor Bugajev, Bridget S. Wilson, Michael Boubelik, Šárka Šímová, Bernard Malissen, Vaclav Horejsi
Publikováno v:
The Journal of Experimental Medicine
Engagement of the Fcepsilon receptor I (FcepsilonRI) on mast cells and basophils initiates signaling pathways leading to degranulation. Early activation events include tyrosine phosphorylation of two transmembrane adaptor proteins, linker for activat
Autor:
Tomas Brdicka, Martin Kovac, Ester Mejstrikova, Martina Vaskova, Petra Volná, Pavla Angelisova, Ondrej Hrusak, Jan Zuna
Publikováno v:
Leukemia Research. 35:1111-1113
The expression of drebrin, a cytoskeletal protein newly estimated by expression profiling to correlate with the genotype and prognosis of B-cell precursor acute lymphoblastic leukemia (BCP-ALL), was examined by independent methods. After demonstratin
Autor:
Petr Dráber, Pavel Lebduška, Petr Heneberg, Jan Korb, Lubica Dráberová, Gouse M. Shaik, Petra Volná, Magda Tůmová
Publikováno v:
Scopus-Elsevier
Engagement of the FcεRI in mast cells and basophils leads to a rapid tyrosine phosphorylation of the transmembrane adaptors LAT (linker for activation of T cells) and NTAL (non-T cell activation linker, also called LAB or LAT2). NTAL regulates activ
Autor:
Tomas Kalina, Ester Mejstrikova, Silvie Bezouskova, Ondrej Hrusak, Martin Kovac, Denisa Petráčková, Jaroslav Weiser, Petra Volná, Martina Vaskova, Vendula Pelkova
Publikováno v:
Blood. 114:1448-1448
Abstract 1448 Poster Board I-471 In acute leukemia (AL), some clinical symptoms may be caused by soluble factors secreted by AL cells into the bone marrow (BM) microenvironment. On the other hand, AL cells are often dependent on the microenviroment o